References
- Mauvais-Jarvis P. Progesterone and progestins: a general overview. Progesterone and Progestins, C. W. Dardin, E. Milgröm, P. Mauvais-Jarvis. Raven Press, New York 1983; 1–16
- Nahoul R., Dhemin L., Jondet M., Roger M. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol and progesterone. Maturitas 1993; 16: 185–202
- Steingold K., Stumpf P., Kremer D., Liu H. C., Navot D., Rosenwaks Z. Estradiol and progesterone replacement regimens for the induction of endometrial receptivity. Fertil. Steril. 1989; 52: 756–60
- Simon J. A., Robinson D. E., Andrews M. C., Hildebrand J. R., Rocci M. L., Blake R. E., Hodgen G. D. The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil. Steril 1993; 60: 26–33
- Simon J. A. Micronized progesterone: vaginal and oral uses. Clin. Obstet. Gynecol 1995; 38: 902–14
- Lutjen P., Trounson A., Leeton J., Findlay J., Wood C., Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature (London) 1984; 307: 174–5
- Navot D., Laufer N., Kopolovic J., Rabinowitz R., Birkenfeld A., Lewin A., Granat M., Mar-Galioth E. J., Schenker J. G. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. N. Engl. J. Med. 1986; 314: 806–11
- Bourgain C., Devroey P., VanWaesberghe L. V., Smitz J., Van Steirteghem A. C. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. Hum. Reprod. 1990; 5: 537–43
- DeZiegler D., Scharer E., Seidler L., Fanchin R., Bergeron C. Transvaginal administration of progesterone: the vaginal paradox and the first uterine pass effect hypothesis. Ref. Cynecol. Obstet. 1995; 3: 267–72
- Balasch J., Vanrell J. A. Corpus luteum insufficiency and fertility: a matter of controversy. Hum. Reprod. 1987; 2: 557–67
- Balasch J., Creus M., Fábregues F., Carmona F., Casamitjana R., Peñarrubia J., Rivera F., Vanrell J. A. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support. Gynecol. Endocrinol 1995; 9: 51–8
- Noyes R. W., Hertig A. T., Rock J. Dating the endometrial biopsy. Fertil. Steril. 1950; 1: 3–25
- Sathanandan M., Macnamee M. C., Rainsbury P., Wick K., Brinsden P., Edwards R. G. Replacement of frozen-thawed embryos in artificial and natural cycles: a prospective semi-randomized study. Hum. Reprod. 1991; 6: 685–7
- Meldrum D. R. Oocyte donation. Infertil. Reprod. Clin. N. Am. 1993; 4: 761–8
- Price J. H., Ismail H., Growill R. H., Sarda I. R. Effect of the suppository base on progesterone delivery from the vagina. Fertil. Steril. 1983; 39: 490–3
- Arafat E. S., Hargrove J. T., Maxson W. S., Desiderios D. M., Wentz A. C., Anderson R. N. Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites. Am. J. Obstet. Gynecol 1988; 159: 1203–9
- Maxson W. S., Hargrove J. T. Bioavailability of oral micronized progesterone. Fertil. Steril 1985; 44: 622–6
- Miles R. A., Paulson R. J., Lobo R. A., Press M. F., Dahmoush L., Sauer M. V. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil. Steril 1994; 62: 485–90
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. J. Am. Med. Assoc. 1995; 273: 199–208